Hair loss under the microscope: new study observes women on fibroid drug
NCT ID NCT06058728
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 24 times
Summary
This study watches women with uterine fibroids who are already taking the drug Oriahnn for heavy bleeding. Researchers want to see how many experience hair loss, when it starts, and if it goes away. About 1,600 women will fill out questionnaires for up to 24 months. No new treatments are tested—this is just to gather information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE FIBROIDS (UF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dorsata /ID# 252675
Arlington, Virginia, 22201-5330, United States
Conditions
Explore the condition pages connected to this study.